Common CAPA Documentation Mistakes and How to Avoid Them
Corrective and Preventive Action (CAPA) is one of the most important elements of a quality management system. Regulators and auditors view CAPA as evidence of an organization's ability to identify issues, investigate root causes, implement corrective actions, and...
FDA Inspection Do’s and Don’ts for Life Science Companies
FDA inspections are a critical part of ensuring life science companies maintain compliance with applicable regulations and quality system requirements. Whether your organization operates in the medical device, pharmaceutical, biotechnology, diagnostic, or clinical...
Common FDA 483 Findings and How to Avoid Them
Understanding FDA 483 Observations An FDA Form 483 is issued when an FDA investigator identifies conditions that may violate the Food Drug and Cosmetic Act or related regulations during an inspection. Receiving a 483 does not automatically mean a company will receive...
FDA Inspection Readiness Guide: Common Questions, 483 Risks, and How to Prepare
What should we expect during an FDA inspection? FDA inspections are structured but can vary depending on the product type, facility, and inspection scope. Typically, inspectors will: • Review your Quality Management System (QMS) • Assess compliance with applicable...
Supplier Qualification Under ISO 13485: A Practical Guide
Under ISO 13485, organizations are expected to apply controls to suppliers, contractors, and consultants based on the effect their products or services can have on the quality of the medical device. That sounds straightforward in theory. In practice, many companies...
When Quality Backlogs Start to Build: Why They Matter and How to Regain Control
In regulated industries, backlogs are rarely just an administrative inconvenience. They are often an early warning sign that a quality system is under strain. As companies scale manufacturing, expand testing, launch new products, or work through periods of...